Navigation Links
ADVENTRX Pharmaceuticals Reports Second Quarter Financial Results
Date:8/12/2009

escribed in ADVENTRX's press releases and periodic filings with the Securities and Exchange Commission. ADVENTRX's public filings with the Securities and Exchange Commission are available at www.sec.gov.

You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date when made. ADVENTRX does not intend to update any forward-looking statement as set forth in this press release to reflect events or circumstances arising after the date on which it was made.

[Tables to Follow]

                         ADVENTRX Pharmaceuticals, Inc.
                        (A Development Stage Enterprise)
                   Summary Consolidated Financial Information
                      (In 000s except for per share data)

    Consolidated Statement of Operations Data:

                                        Three Months         Six Months
                                        Ended June 30,      Ended June 30,
                                      2009       2008       2009      2008
                                  (unaudited)(unaudited)(unaudited)(unaudited)

    Revenues                              $-      $500       $300       $500

    Operating expenses:
      Research and development         1,455     4,511      3,102      8,332
      Selling, general and
       administrative                  1,071     2,636      2,851      5,001
      Depreciation and amortization       26        45         58         91
        Total operating expenses       2,552     7,192      6,011     13,423

    Loss from operations              (2,552)   (6,691)    (5,711)   (12,923)

      Interest / Other income            (43)      266        (41)       565
    Loss before income taxes          (2,596)   (6,426)    (5,753)   (12,359)

 
'/>"/>
SOURCE  ADVENTRX Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 

Related biology technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. ADVENTRX Pharmaceuticals to Present at the 20th Annual Bear Stearns Healthcare Conference
4. ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA
5. ADVENTRX Pharmaceuticals to Present at the ThinkEquity Partners Fifth Annual Growth Conference
6. ADVENTRX Pharmaceuticals to Present at the 2007 UBS Global Life Sciences Conference
7. ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference
8. ADVENTRX Pharmaceuticals to Present at the 2007 BIOInvestor Forum
9. ADVENTRX Appoints Vice President of Commercialization
10. ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results
11. ADVENTRX Announces Consolidation of Clinical and Management Positions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... , May 16, 2013  HealthSparq, a ... of the nation,s largest regional health plans, will ... Health Insurance Plans (AHIP) Institute 2013 conference on ... survey results showing how health insurance companies across ... the consumer and marketplace demands for increased healthcare ...
(Date:5/16/2013)... 16, 2013 As the weather warms, women ... favorite Spring looks. While most make a statement with fashion, ... women find the warmer weather mixes makeup and sweat to ... the onset of acne during warmer months, Adult Acne ... treatment users the best ways to deter breakouts. , ...
(Date:5/16/2013)... 16, 2013 Reportlinker.com announces ... is available in its catalogue: ... for Acute Coronary Syndromes - APAC ... http://www.reportlinker.com/p01182969/MediPoint-Diagnostic-Cardiac-Biomarkers-for-Acute-Coronary-Syndromes---APAC-Analysis-and-Market-Forecasts.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic MediPoint: ... Syndromes - APAC Analysis and Market ...
(Date:5/16/2013)... 16, 2013 Dr. Stephen Y. Chou, ... titled “Nanoimprint Lithography and Applications” at IEEE Nano 2013 ... invented in 1995 by Chou, is becoming one of ... unique combination of sub-10 nm resolution, large area, and ... impacting both R&D and manufacturing in a broad range ...
Breaking Biology Technology:HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3Adult Acne Treatment, Probiotic Action Shares New Tips for Women on How to Fight Acne While Wearing Makeup 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 3MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 4MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 5MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 6MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 7MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 8Founder, Prof. Stephen Chou to Give Tutorial on Nanoimprint at IEEE Nano 2013 2
... NEW YORK, May 13 Johnson & Johnson ... and Emeritus Professor Sir,Ravinder N. Maini, FRCP, FMedSci, ... London have been named the recipients of the,2008 ... an independent,selection committee of world-renowned scientists., The ...
... Ltd.,announced today the appointment of Prof. Arie Schachner to ... Dr. Schachner has been a member of Meditor,s Scientific ... active role in the Clinical Development,program., Prof. Schachner ... at Wolfson Medical Center and Tel Aviv University Sackler,Medical ...
... Calif., May 12 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ... March 31, 2008 and provided an update on the,Company,s ... the 2008,first fiscal quarter, as reported in accordance with ... $14.6 million, compared,to a net loss of $10.9 million ...
Cached Biology Technology:Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research 2Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research 3Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research 4Two New Appointments at Meditor Pharmaceuticals Ltd. 2Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 2Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 3Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 4Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 5Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 6Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 7Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 8Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 9Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 10
(Date:5/16/2013)... Integrated Biometrics patented LES (Light Emitting ... film transistor camera introduces Sherlock, a fingerprint scanner ... the smallest and lightest form factor available on ... ID FAP 45, Certified scanner is highly efficient ... weight when compared to optical scanners. ...
(Date:5/16/2013)... world are meeting next week in Toronto. The ... latest in research findings about the brain, the ... disorders that affect them., "Canada is a leader ... the best of neuroscience research done here and ... the Canadian Association for Neuroscience. He also reminds ...
(Date:5/15/2013)... gout risk, new research reveals that vitamin C, also ... levels to a clinically significant degree in patients with ... with allopurinol, appears to have a weak effect on ... the results published in the American College of Rheumatology ... Gout is an inflammatory arthritis that causes excruciating pain ...
Breaking Biology News(10 mins):7th Annual Canadian Neuroscience Meeting, Toronto, May 20-24, 2013 2Vitamin C does not lower uric acid levels in gout patients 2
... Indian announced that it has been awarded a ... Building Council and verified by the Green Building ... Design, is the nation,s preeminent program for the ... "This achievement not only signifies the Smithsonian ...
... 6, 2011Measurable changes in brain function and communication between ... during the early stages of human immunodeficiency virus (HIV) ... are detailed in an article in the groundbreaking new ... bimonthly peer-reviewed journal published by Mary Ann Liebert, ...
... reduce size and improve performance and cell life is ... by Penn State and funded by the Department of ... $5 million, three-year grant is part of the DOE,s ... improving fuel efficiency of next generation vehicles. Penn ...
Cached Biology News:National Museum of the American Indian awarded prestigious LEED Green Building Certification 2Changes in brain function in early HIV infection: A reliable indicator of disease prognosis? 2
...
... Immunogen: purified recombinant human ... coli . Physical form: ... filtered solution in phosphate buffered ... (c). WB. Titertest ...
Request Info...
2 ml SmartScan Racks...
Biology Products: